According to ACMG/AMP criteria, the FBLN5 variant was classified as pathogenic, consistent with autosomal recessive cutis laxa type 1A, while the TNFRSF13B variant was considered a secondary finding of uncertain clinical significance. Here, FBLN5 is linked to autosomal recessive cutis laxa type 1.